Follistatin-344 (FS-344) Dosing Protocol: Myostatin Inhibitor Guide
Also known as: FS-344, FS-315 Precursor, Myostatin & Activin-A Antagonist Peptide
Studied in published research — not a medical recommendation. Primary protocol (Short-Pulse 10-Day SubQ / Local Recovery Protocol): 100 mcg once daily, Daily for 10 consecutive days.
Daily for 10 consecutive days
Research-reported range; the linked study used a different dose or units. Standard 1 mg lyophilized vial yields exactly ten 100 mcg daily doses; must be stored refrigerated and handled gently without shaking
Subcutaneous or bilateral local intramuscular injection
Published peer-reviewed research & clinical protocols
No verified human half-life on file for this compound
A vial is powder until you add bacteriostatic water. Change the vial size or water volume below to see the exact unit mark on your syringe.
All U-100: 100 units = 1 mL. 50 doses in the vial at the low end.
Save Follistatin-344 to your personal protocol list to log your custom dosage, syringe units, ON/OFF cycle dates, and lab notes across devices.
At a Glance · 2026 FDA / 503A / WADA / Evidence Profile
What is a Peptide?
A short chain of amino acids (2-50) linked by peptide bonds. Smaller than proteins. Your body produces thousands of peptides naturally as signaling molecules that regulate everything from appetite to healing. Therapeutic peptides mimic or enhance these natural signals.
Bottom Line Up Front
Follistatin-344 (FS-344) is an autocrine glycoprotein precursor that binds and neutralizes Myostatin (GDF-8) and Activin A to lift the endogenous brake on skeletal muscle hypertrophy and satellite cell proliferation.
Myostatin (GDF-8) neutralization and muscle fiber regeneration (AAV1-FS344 human gene therapy & animal models)
Sustained systemic hypertrophy from low-dose subcutaneous peptide injections in healthy adults
None
3 (1 human)
EDUCATIONAL AND RESEARCH REFERENCE ONLY — NOT MEDICAL ADVICE. Follistatin-344 is not FDA approved for human use (unless specified above). This information does not constitute medical advice.
Overview
Myostatin (Growth Differentiation Factor-8, GDF-8) acts as a chalone that limits skeletal muscle mass by inhibiting satellite cell proliferation and myoblast differentiation via ActRIIB receptors. Follistatin is a naturally occurring cysteine-rich glycoprotein that wraps around Myostatin and Activin A dimers in a 2:1 stoichiometric complex, blocking receptor binding. The 344-amino-acid isoform (FS-344) yields the circulating 315-AA form (FS-315), which includes an acidic C-terminal tail that prevents indiscriminate binding to cell-surface heparan sulfate proteoglycans (unlike FS-288), making FS-344/315 the preferred isoform for selective skeletal muscle signaling without reproductive/pituitary FSH disruption.
Mechanisms of Action
- Binds and neutralizes extracellular Myostatin (GDF-8) dimers with picomolar affinity, preventing ActRIIB receptor phosphorylation
- Antagonizes Activin A and GDF-11 signaling to reduce Smad2/3 catabolic transcription and upregulate mTOR/Akt protein synthesis
- Stimulates quiescent Pax7+ skeletal muscle satellite cells to proliferate and fuse into damaged myofibers
- C-terminal acidic domain of FS-344/FS-315 reduces cell-surface heparan sulfate trapping compared to tissue-bound FS-288
Research Protocols
Summaries of published research. For educational purposes only.
GH / IGF-1 & Glycemic Sensitivity Biomarker Panel (Follistatin-344)
Growth hormone secretagogues and somatomedin analogs directly elevate hepatic IGF-1 and can shift fasting insulin sensitivity via GH counter-regulatory signaling.
Serum IGF-1 (LC/MS) + Z-Score
Day 0 + Wk 6–8Why track at baseline: Establishes baseline somatotropic output before pituitary or local IGF-1R stimulation.
Week 6–8 check: Confirm physiological upper-quartile elevation (typically +30% to +80% above baseline) without supraphysiological overshoot (>300 ng/mL).
Fasting Insulin & HOMA-IR
Day 0 + Wk 6–8Why track at baseline: Pituitary GH pulses promote free fatty acid mobilization, which can transiently reduce peripheral insulin sensitivity.
Week 6–8 check: Keep Fasting Insulin <6–8 uIU/mL; if elevated, enforce strict 2–3 hr pre-bed fasting before GH secretagogue administration.
HbA1c & Fasting Plasma Glucose
Day 0 + Wk 6–8Why track at baseline: Screens for subclinical prediabetes prior to growth-factor or secretagogue exposure.
Week 6–8 check: Verify stable 90-day glycemic control (HbA1c <5.4% optimal) at Week 6–8.
hs-CRP, Prolactin & CMP
Day 0 + Wk 6–8Why track at baseline: Checks systemic inflammation, pituitary selectivity (no off-target prolactin/cortisol rise), and hepatic/renal clearance.
Week 6–8 check: Confirm Ipamorelin/CJC/Tesamorelin selectivity with unchanged Prolactin and normal liver transaminases.
Related Studies
Intramuscular delivery of AAV1.CMV.FS344 in patients with Becker muscular dystrophy improved 6-minute walk distance and produced histological muscle fiber regeneration and reduced fibrosis without serious adverse events.
Limitations: Human trial utilized viral vector (AAV1) expression of FS-344 rather than daily subcutaneous recombinant peptide injections.
Community Outcomes
Community Data Coming Soon
Aggregate community outcomes will be displayed here once we have more reports. Be one of the first to share your experience!
Outcomes are self-reported and unverified. They represent individual experiences and may not reflect typical results.
Important Warnings
- •Prohibited at all times by WADA under Section S4.3 (Agents preventing Activin receptor IIB activation / Myostatin inhibitors)
- •Because Activin A also regulates tendon fibroblast remodeling, rapid muscle strength gains without progressive tendon loading can increase tendon strain risk
- •Full-length recombinant glycoproteins are fragile and expensive to synthesize; verify MW (~35–38 kDa) and purity on third-party COAs
- •May transiently suppress pituitary FSH if dosed excessively due to Activin neutralization
Where to get Follistatin-344, baseline labs & clinician oversight.
Ascension Peptides (US Vials)
MZ Biolabs & SafeCert COA-verified US domestic single vials with 50% off auto-applied for new customers.
SwissChems & Limitless Biotech
Same-day US domestic lyophilized vials, oral capsules, and endotoxin-screened nasal sprays (15% off Limitless w/ code PEPTIDEPROTOCOLS).
Superpower Labs & 503A Telehealth
Bloodwork, not a vial store. Get a baseline panel (100+ Quest biomarkers: metabolic, lipids, hormones, inflammation, kidney/liver) before you start a peptide protocol, then retest mid-cycle to see what actually changed.
Peptide Reconstitution & U-100 Syringe Cheat Sheet
Printable U-100 insulin syringe draw chart for 5mg–50mg vials, plus our weekly $/mg price-drop brief.
Related Peptides
More recovery peptides
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a prote...
TB-500 (Thymosin Beta-4)
TB-500 is the synthetic version of Thymosin Beta-4, a natura...
Wolverine Blend (BPC-157 + TB-500)
The Wolverine Blend (BPC-157 + TB-500) is the gold-standard ...
ARA-290 (Cibinetide)
ARA-290 is a non-erythropoietic peptide derived from erythro...
PEG-MGF (Mechano Growth Factor)
MGF is a splice variant of IGF-1 produced locally in muscle ...
Vendor vs vendor: price per mg
Head-to-head $/mg on shared compounds. Prices verified Nov 11, 2026.
- Ascension vs SwissChems (3 shared compounds)
- Elite vs SwissChems (3 shared compounds)
- Elite vs Ascension (26 shared compounds)
- Protide vs SwissChems (3 shared compounds)
- Protide vs Ascension (6 shared compounds)
- Ameano vs SwissChems (3 shared compounds)
- Ameano vs Ascension (4 shared compounds)
- Swift vs Ascension (23 shared compounds)
- BioLongevity vs Ascension (16 shared compounds)
- Peptyes vs SwissChems (3 shared compounds)
- Peptyes vs Elite (20 shared compounds)
- Peptyes vs Swift (17 shared compounds)
- Peptyes vs Pure (17 shared compounds)
- Peptyes vs Ascension (20 shared compounds)
Compound vs compound: BPC-157 vs TB-500 · Tirzepatide vs Semaglutide · Retatrutide vs Tirzepatide · Wolverine Blend vs GLOW Blend · Semax vs Selank · KLOW Blend vs GLOW Blend · MOTS-c vs SS-31 · Sermorelin vs Ipamorelin · Retatrutide vs Semaglutide · Tesamorelin vs Sermorelin · All compounds $/mg →
Common questions
How many peptides are in the database?
100 compound pages, each with dosing references, reconstitution math and price per mg where a verified vendor price exists.
Where can I compare peptide prices?
Each compound page shows verified $/mg by vendor; the vendor-vs-vendor pages above compare two vendors across their shared compounds.